CD34 and acute myeloid leukemia: Adamia et al. [94] proved that aberrant splicing was a common characteristic of AML and approximately 29% genes, encoding oncogenes, tumor suppressors, proteins implicated in splicing, apoptosis, cell cycle regulation, cell proliferation and differentiation, were aberrantly spliced in AML, as compared to normal CD34+ BM cells.